Colchicine
18
5
6
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 42/100
5.6%
1 terminated out of 18 trials
83.3%
-3.3% vs benchmark
56%
10 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (18)
Precision Colchicine Intervention to Suppress Atherosclerosis in TET2 Clonal Hematopoiesis
The Effect of Colchicine on the Occurrence of Atrial Fibrillation After Cardiac Surgery
Efficacy and Safety of Colchicine After PCI
Pilot Trial of Colchicine for Graft Failure in CABG
Colchicine for the Reduction of Dependency and Vascular Events After an Acute Intracerebral Hemorrhage
Colchicine And Dialysis Patients; a Feasibility Study
Colchicine's Effect on Inflammatory Markers
Colchicine for Patients With Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement
Low-dose Colchicine for CABG Graft Failure Prevention
Colchicine in Patients With Heart Failure and Preserved Left Ventricular Ejection Fraction
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
Colchicine in Patients with Heart Failure with Preserved Ejection Fraction and Inflammation
Colchicine in HFpEF
Effect of Colchicine on MMP-9, NOX2, and TGF-β1 in Myocardial Infarct
Effect of Colchicine On Left Ventricle Function After Anterior Myocardial Infarction Assessed By Speckle Tracking
Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery Disease
Low-dose Colchicine Inhibit Abdominal Aortic Aneurysm Growth Trial
Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19